The economic advantages of measured change in health care: An example from obstetrics

C. E L Brown, A. J. Satin, K. J. Leveno

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To evaluate the economic effects of an increased oxytocin dosage for labor stimulation at a large urban hospital, a cost analysis of a before and after cohort, analytic clinical trial was performed. Delivery outcomes for two different oxytocin dosages were evaluated from the perspective of provider and consumer costs attributable to the oxytocin regimen. The high-dose oxytocin regimen resulted in an estimated provider and consumer cost savings of approximately $350,000 per year. We conclude that a small change in health care, such as an increased infusion rate of a single drug, can have economic advantages.

Original languageEnglish (US)
Pages (from-to)893-895
Number of pages3
JournalObstetrics and Gynecology
Volume84
Issue number5
StatePublished - 1994

Fingerprint

Oxytocin
Obstetrics
Economics
Delivery of Health Care
Costs and Cost Analysis
Cost Savings
Hospital Costs
Urban Hospitals
Clinical Trials
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The economic advantages of measured change in health care : An example from obstetrics. / Brown, C. E L; Satin, A. J.; Leveno, K. J.

In: Obstetrics and Gynecology, Vol. 84, No. 5, 1994, p. 893-895.

Research output: Contribution to journalArticle

@article{2304dde98b1a48b48f6cb81c3d08b295,
title = "The economic advantages of measured change in health care: An example from obstetrics",
abstract = "To evaluate the economic effects of an increased oxytocin dosage for labor stimulation at a large urban hospital, a cost analysis of a before and after cohort, analytic clinical trial was performed. Delivery outcomes for two different oxytocin dosages were evaluated from the perspective of provider and consumer costs attributable to the oxytocin regimen. The high-dose oxytocin regimen resulted in an estimated provider and consumer cost savings of approximately $350,000 per year. We conclude that a small change in health care, such as an increased infusion rate of a single drug, can have economic advantages.",
author = "Brown, {C. E L} and Satin, {A. J.} and Leveno, {K. J.}",
year = "1994",
language = "English (US)",
volume = "84",
pages = "893--895",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The economic advantages of measured change in health care

T2 - An example from obstetrics

AU - Brown, C. E L

AU - Satin, A. J.

AU - Leveno, K. J.

PY - 1994

Y1 - 1994

N2 - To evaluate the economic effects of an increased oxytocin dosage for labor stimulation at a large urban hospital, a cost analysis of a before and after cohort, analytic clinical trial was performed. Delivery outcomes for two different oxytocin dosages were evaluated from the perspective of provider and consumer costs attributable to the oxytocin regimen. The high-dose oxytocin regimen resulted in an estimated provider and consumer cost savings of approximately $350,000 per year. We conclude that a small change in health care, such as an increased infusion rate of a single drug, can have economic advantages.

AB - To evaluate the economic effects of an increased oxytocin dosage for labor stimulation at a large urban hospital, a cost analysis of a before and after cohort, analytic clinical trial was performed. Delivery outcomes for two different oxytocin dosages were evaluated from the perspective of provider and consumer costs attributable to the oxytocin regimen. The high-dose oxytocin regimen resulted in an estimated provider and consumer cost savings of approximately $350,000 per year. We conclude that a small change in health care, such as an increased infusion rate of a single drug, can have economic advantages.

UR - http://www.scopus.com/inward/record.url?scp=0028033186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028033186&partnerID=8YFLogxK

M3 - Article

C2 - 7936534

AN - SCOPUS:0028033186

VL - 84

SP - 893

EP - 895

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -